elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33785927-23836F54-C1DC-44FE-A5A9-804D1F9D8DF2
Q33785927-23836F54-C1DC-44FE-A5A9-804D1F9D8DF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33785927-23836F54-C1DC-44FE-A5A9-804D1F9D8DF2
A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602).
P2093
Q33785927-23836F54-C1DC-44FE-A5A9-804D1F9D8DF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33785927-23836F54-C1DC-44FE-A5A9-804D1F9D8DF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8cc9a69c5a606c02c59fe846003e0154e70e9246
P1545
9
http://www.w3.org/2001/XMLSchema#string
P2093
Cancer and Leukemia Group B (CALGB)
http://www.w3.org/2001/XMLSchema#string